TheProfitWatch

GTBP - GT Biopharma Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.69 0.06 (8.74%) 0.01 (1.39%) 0.01 (1.39%) -0.01 (-0.7%) 0.0 (0.03%) 0.03 (4.5%) 0.0 (0.0%) -0.01 (-2.03%)

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.55
Diluted EPS:
-0.55
Basic P/E:
-1.3642
Diluted P/E:
-1.3642
RSI(14) 1m:
50.25
VWAP:
0.75
RVol:

Events

Period Kind Movement Occurred At

Related News